CORDUA, ALESSIA
 Distribuzione geografica
Continente #
EU - Europa 56
NA - Nord America 36
AS - Asia 16
Totale 108
Nazione #
IT - Italia 40
US - Stati Uniti d'America 36
SG - Singapore 13
NL - Olanda 6
GB - Regno Unito 3
AT - Austria 2
IN - India 2
RU - Federazione Russa 2
DE - Germania 1
FI - Finlandia 1
FR - Francia 1
IR - Iran 1
Totale 108
Città #
Chandler 6
Chicago 6
Ercolano 4
London 3
Paola 3
Rome 3
Singapore 3
Delhi 2
Gesuiti 2
San Nicola Manfredi 2
Santa Clara 2
Ashburn 1
Cosenza 1
Helsinki 1
Lawrence 1
Naples 1
Nuremberg 1
Palermo 1
Princeton 1
St Petersburg 1
Vienna 1
Totale 46
Nome #
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 52
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 51
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 9
A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer 6
Totale 118
Categoria #
all - tutte 879
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 879


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202214 0 0 0 0 0 0 0 0 9 5 0 0
2022/202318 2 1 1 0 4 3 0 1 2 3 1 0
2023/202432 15 3 4 1 1 3 0 0 0 0 3 2
2024/202554 5 2 1 4 6 16 8 3 7 2 0 0
Totale 118